05:48 PM EST, 02/02/2026 (MT Newswires) -- Pelthos Therapeutics ( PTHS ) filed a shelf registration statement with US regulators on Monday for the potential sale of up to $200 million in securities, to be offered from time to time.

The filing covers common stock, preferred stock, debt securities, warrants, rights and units.

The company plans to use offering proceeds for general corporate purposes, with specific uses outlined in the applicable prospectus supplement, it added.